Departure of Randy Slikkers

Randy has been the GRMA’s CEO/Executive Director for the last two years, was a key driver with establishing the GRMA as a non-profit organization and we wish him luck with his pursuit of other opportunities outside of the GRMA. The GRMA would like to thank Randy for his contributions and leadership over the last two years and is appreciative of Randy’s guidance to the board, direction over the annual summit, and key contributions with both the pilot audit program and certification scheme. The [Read more]

GRMA is in the process of developing a Medical Device/Consumer Product (MD/CP) Standard. Our goal is to utilize a group of key industry stakeholders that represent the MD/CP sector to develop the standard over the remainder of 2019 and into the first quarter of 2020. Our strategy is to create a standard based on product risk that would encompass consumer goods, making the potential for true global acceptance. The GRMA will then adapt this standard into its array of audit schemes. This process is known as the “protocol method”. This [Read more]

Panel Discussion: CBD Product Standard Development: Alan Perlman (NSF) moderated a panel discussion of industry leaders at the GRMA Summit which centered around the complexities of the industry in relation to developing GMP Standards. Key discussion points included the need to connect GRMA with current GMP standard development activity by the industry. The question was raised as to the need to develop an entirely new standard or the potential to adopt the 455-2 Dietary Supplement Standard. Also discussed was the difficulty of working around the inclusion of hemp in the [Read more]

by Stephen Daniells

NutraIngredients-USA is pleased to announce the finalists for the NutraIngredients-USA Awards 2019… the winners will be announced at our awards evening in New Orleans on June 3rd.

Read more